Akebia Therapeutics, Inc. (AKBA) vs Lifecore Biomedical, Inc. (LFCR)
- Akebia Therapeutics, Inc. AKBA 0.67 −4.29%
- Lifecore Biomedical, Inc. LFCR 6.38 −0.93%
Akebia Therapeutics, Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. is the larger, with a market value of $244.1M against $192.7M — 1.3× the size. Akebia Therapeutics, Inc. grew revenue faster over the last twelve months: 7.52% against −10.0%. Akebia Therapeutics, Inc. has the higher net margin (−13.5% vs −37.5%) and the higher return on invested capital (0.00% vs −2.80%). Across the 17 metrics below, Akebia Therapeutics, Inc. leads on 11 and Lifecore Biomedical, Inc. on 6.
Valuation
Profitability
| Metric | AKBA | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 79.63% | 26.86% | 53.94% |
| Operating margin | (6.90%) | (6.89%) | 0.00% |
| Net margin | (13.54%) | (37.54%) | 0.00% |
| Free cash flow margin | 18.38% | (4.24%) | 0.00% |
| Return on equity | (109.38%) | 201.15% | (0.40%) |
| Return on assets | (8.53%) | (19.32%) | (3.32%) |
| Return on invested capital | 0.00% | (2.80%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack